Predigen News
- Aug 26, 2021
- 1 min read

Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critic

Biomeme and long-time collaborator, Predigen, have entered an agreement to merge in order to expand Biomeme's diagnostic capabilities. Combining Predigen's extensive years of host response research with Biomeme's gold-standard, portable real-time PCR platform, this merger marks an exciting next step for this innovative partnership.

Read full press release here.

Recent Posts

Blood-based test IDs viral infection before symptoms appear

By Meg Bryant for BioWorld September 25, 2020 A team of scientists at Duke Health has identified biomarkers that accurately detect viral infections before a person becomes symptomatic. The findings,

Blood-based Host Response Test Predicts Respiratory Viral Infection in Pre-symptomatic Patients

Study Reveals Blood-based Host Response Test Can Accurately Predict Respiratory Viral Infection in Pre-symptomatic Patients Predigen Developing Diagnostic Tools Designed to Help Physicians Differentia

Bacterial, Viral, or Neither? Host Response Test Has Answers

By Deborah Borfitz January 2, 2020 | A Duke University spin-out company is putting the last touches on a host response bacterial-viral test entering the final leg of the Antimicrobial Resistance (AMR)